• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

BTI's Magnes II cleared in Japan

Article

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The actionmeans that Magnes II can be marketed in other Asian countriesthat recognize the Japanese agency's approval.

On the downside, BTI last month posted lower financial numbersfor its third quarter (end-June). Revenues for the quarter were$1.8 million, down 27% compared to $2.5 million in the same periodin 1994. The firm's net loss was $2.2 million, which includeda non-recurring charge of $595,000, compared to a net loss of$1.4 million in the third quarter of 1994.

The company's backlog is at $11.3 million, however, which isthe highest level in BTI's history. It was aided by an order inAugust for a Magnes Whole Head system, a next-generation MSI scannerintroduced at last year's Radiological Society of North Americameeting (SCAN 3/15/95). That system will be shipped to the Institutefor Research in Neurosciences and Psychiatry in Rouffach, France.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.